Bloomberg
😐 Neutral
Island Pharma Jumps After Emergency-Use Approval for Ebola Drug
Australia’s Island Pharmaceuticals Ltd. surged as much as 47% after saying its experimental antiviral galidesivir had secured regulatory and ethics approvals for emergency use in patients with the Bundibugyo strain of Ebola in Uganda.
Comments (0)
Leave a Comment
No comments yet. Be the first to comment!